Results High doses of GLP1-based multi-agonists improve metabolic function in murine models of PCOS We explored metabolic, hormonal, and gonadal responses to different GLP1-based multi-agonists in two experimental (mouse) models of PCOS, namely PWA (postweaning androgenization) and PNA (prenatal androgenization)
Acta 1830 , 33503353 (2013)
GLP-1/GIP + B6 combines dual GLP-1/GIP support with Vitamin B6 to support metabolic health, appetite awareness, energy balance, and overall wellness as part of a structured lifestyle routine
CROCC, also known as TAX1BP2, is a tumor-suppressor gene that was shown to suppress hepatocellular carcinoma via p38/p53/p21 pathway activation 38
History of gastrointestinal disorders (e.g., gastroparesis or inflammatory bowel disease), as semaglutide may slow gastric emptying and worsen these diseases
Support medical treatment of obesity with related conditions under close medical supervision